METHOD FOR EXTRAPROSTATIC EXTENSION FORECASTING OF PATIENTS WITH PROSTATE CANCER

FIELD: medicine. ^ SUBSTANCE: following risk factors are defined before operation: clinical stage of prostate cancer, degree of malignancy of new growths under the scale of Glison, number positive biopsy columns, level of prostate specific antigene (PSA) in blood plasma, presence of perineural invas...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: AL'-SHUKRI SAL'MAN KHASUNOVICH, KOZLOV VLADIMIR VIKTOROVICH, BOROVETS SERGEJ JUR'EVICH
Format: Patent
Sprache:eng ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator AL'-SHUKRI SAL'MAN KHASUNOVICH
KOZLOV VLADIMIR VIKTOROVICH
BOROVETS SERGEJ JUR'EVICH
description FIELD: medicine. ^ SUBSTANCE: following risk factors are defined before operation: clinical stage of prostate cancer, degree of malignancy of new growths under the scale of Glison, number positive biopsy columns, level of prostate specific antigene (PSA) in blood plasma, presence of perineural invasion. Then indicator of extraprostatic extension is counted under the formula: D=0.08xT+0.08xG+0.05xB+0.8xPSA+0.9xP where: D is indicator of extraprostatic extension; T is clinical stage of prostate cancer: 1 - T2a, 2 - T2b; G - degree of malignancy of new growths under the scale of Glison: 2-10; B - number of positive biopsy columns: 1-6; PSA-level in blood plasma is more than 10 ng per ml: 0 - no; 1 - yes, P - presence of perineural invasion: 0 - no; 1 - yes and at value D>1.25 extraprostatic extension is predicted. ^ EFFECT: possibility of forecasting with high accuracy of probability of extraprostatic extension of patients with prostate cancer. ^ 1 tbl, 3 ex
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RU2336826C1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RU2336826C1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RU2336826C13</originalsourceid><addsrcrecordid>eNrjZAjwdQ3x8HdRcPMPUnCNCAlyDAjyDw5xDPF0BnFd_YI9_f1Akq7OjsEhnn7uCv5uCgFAaVe_kGCFcM8QDwWoBlcFZ0c_Z9cgHgbWtMSc4lReKM3NoODmGuLsoZtakB-fWlyQmJyal1oSHxRqZGxsZmFk5mxoTIQSAGByL1E</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>METHOD FOR EXTRAPROSTATIC EXTENSION FORECASTING OF PATIENTS WITH PROSTATE CANCER</title><source>esp@cenet</source><creator>AL'-SHUKRI SAL'MAN KHASUNOVICH ; KOZLOV VLADIMIR VIKTOROVICH ; BOROVETS SERGEJ JUR'EVICH</creator><creatorcontrib>AL'-SHUKRI SAL'MAN KHASUNOVICH ; KOZLOV VLADIMIR VIKTOROVICH ; BOROVETS SERGEJ JUR'EVICH</creatorcontrib><description>FIELD: medicine. ^ SUBSTANCE: following risk factors are defined before operation: clinical stage of prostate cancer, degree of malignancy of new growths under the scale of Glison, number positive biopsy columns, level of prostate specific antigene (PSA) in blood plasma, presence of perineural invasion. Then indicator of extraprostatic extension is counted under the formula: D=0.08xT+0.08xG+0.05xB+0.8xPSA+0.9xP where: D is indicator of extraprostatic extension; T is clinical stage of prostate cancer: 1 - T2a, 2 - T2b; G - degree of malignancy of new growths under the scale of Glison: 2-10; B - number of positive biopsy columns: 1-6; PSA-level in blood plasma is more than 10 ng per ml: 0 - no; 1 - yes, P - presence of perineural invasion: 0 - no; 1 - yes and at value D&gt;1.25 extraprostatic extension is predicted. ^ EFFECT: possibility of forecasting with high accuracy of probability of extraprostatic extension of patients with prostate cancer. ^ 1 tbl, 3 ex</description><language>eng ; rus</language><subject>DIAGNOSIS ; HUMAN NECESSITIES ; HYGIENE ; IDENTIFICATION ; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; MEDICAL OR VETERINARY SCIENCE ; PHYSICS ; SURGERY ; TESTING</subject><creationdate>2008</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20081027&amp;DB=EPODOC&amp;CC=RU&amp;NR=2336826C1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20081027&amp;DB=EPODOC&amp;CC=RU&amp;NR=2336826C1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>AL'-SHUKRI SAL'MAN KHASUNOVICH</creatorcontrib><creatorcontrib>KOZLOV VLADIMIR VIKTOROVICH</creatorcontrib><creatorcontrib>BOROVETS SERGEJ JUR'EVICH</creatorcontrib><title>METHOD FOR EXTRAPROSTATIC EXTENSION FORECASTING OF PATIENTS WITH PROSTATE CANCER</title><description>FIELD: medicine. ^ SUBSTANCE: following risk factors are defined before operation: clinical stage of prostate cancer, degree of malignancy of new growths under the scale of Glison, number positive biopsy columns, level of prostate specific antigene (PSA) in blood plasma, presence of perineural invasion. Then indicator of extraprostatic extension is counted under the formula: D=0.08xT+0.08xG+0.05xB+0.8xPSA+0.9xP where: D is indicator of extraprostatic extension; T is clinical stage of prostate cancer: 1 - T2a, 2 - T2b; G - degree of malignancy of new growths under the scale of Glison: 2-10; B - number of positive biopsy columns: 1-6; PSA-level in blood plasma is more than 10 ng per ml: 0 - no; 1 - yes, P - presence of perineural invasion: 0 - no; 1 - yes and at value D&gt;1.25 extraprostatic extension is predicted. ^ EFFECT: possibility of forecasting with high accuracy of probability of extraprostatic extension of patients with prostate cancer. ^ 1 tbl, 3 ex</description><subject>DIAGNOSIS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>IDENTIFICATION</subject><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PHYSICS</subject><subject>SURGERY</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2008</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZAjwdQ3x8HdRcPMPUnCNCAlyDAjyDw5xDPF0BnFd_YI9_f1Akq7OjsEhnn7uCv5uCgFAaVe_kGCFcM8QDwWoBlcFZ0c_Z9cgHgbWtMSc4lReKM3NoODmGuLsoZtakB-fWlyQmJyal1oSHxRqZGxsZmFk5mxoTIQSAGByL1E</recordid><startdate>20081027</startdate><enddate>20081027</enddate><creator>AL'-SHUKRI SAL'MAN KHASUNOVICH</creator><creator>KOZLOV VLADIMIR VIKTOROVICH</creator><creator>BOROVETS SERGEJ JUR'EVICH</creator><scope>EVB</scope></search><sort><creationdate>20081027</creationdate><title>METHOD FOR EXTRAPROSTATIC EXTENSION FORECASTING OF PATIENTS WITH PROSTATE CANCER</title><author>AL'-SHUKRI SAL'MAN KHASUNOVICH ; KOZLOV VLADIMIR VIKTOROVICH ; BOROVETS SERGEJ JUR'EVICH</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RU2336826C13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; rus</language><creationdate>2008</creationdate><topic>DIAGNOSIS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>IDENTIFICATION</topic><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PHYSICS</topic><topic>SURGERY</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>AL'-SHUKRI SAL'MAN KHASUNOVICH</creatorcontrib><creatorcontrib>KOZLOV VLADIMIR VIKTOROVICH</creatorcontrib><creatorcontrib>BOROVETS SERGEJ JUR'EVICH</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>AL'-SHUKRI SAL'MAN KHASUNOVICH</au><au>KOZLOV VLADIMIR VIKTOROVICH</au><au>BOROVETS SERGEJ JUR'EVICH</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>METHOD FOR EXTRAPROSTATIC EXTENSION FORECASTING OF PATIENTS WITH PROSTATE CANCER</title><date>2008-10-27</date><risdate>2008</risdate><abstract>FIELD: medicine. ^ SUBSTANCE: following risk factors are defined before operation: clinical stage of prostate cancer, degree of malignancy of new growths under the scale of Glison, number positive biopsy columns, level of prostate specific antigene (PSA) in blood plasma, presence of perineural invasion. Then indicator of extraprostatic extension is counted under the formula: D=0.08xT+0.08xG+0.05xB+0.8xPSA+0.9xP where: D is indicator of extraprostatic extension; T is clinical stage of prostate cancer: 1 - T2a, 2 - T2b; G - degree of malignancy of new growths under the scale of Glison: 2-10; B - number of positive biopsy columns: 1-6; PSA-level in blood plasma is more than 10 ng per ml: 0 - no; 1 - yes, P - presence of perineural invasion: 0 - no; 1 - yes and at value D&gt;1.25 extraprostatic extension is predicted. ^ EFFECT: possibility of forecasting with high accuracy of probability of extraprostatic extension of patients with prostate cancer. ^ 1 tbl, 3 ex</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; rus
recordid cdi_epo_espacenet_RU2336826C1
source esp@cenet
subjects DIAGNOSIS
HUMAN NECESSITIES
HYGIENE
IDENTIFICATION
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
PHYSICS
SURGERY
TESTING
title METHOD FOR EXTRAPROSTATIC EXTENSION FORECASTING OF PATIENTS WITH PROSTATE CANCER
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T12%3A55%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=AL'-SHUKRI%20SAL'MAN%20KHASUNOVICH&rft.date=2008-10-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERU2336826C1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true